Food on Prescription Conference - 2026

This panel will examine the role of GLP-1 therapies in managing weight, metabolic syndrome, and chronic disease, with a focus on the practical and clinical challenges. Dr David Unwin, Dr Zoe Harcombe, and Zoe Griffiths will discuss issues such as accessibility, long-term sustainability, side effects, and how these treatments can complement dietary and lifestyle interventions. The session will provide a critical, evidence-informed perspective on integrating GLP-1 therapies into holistic approaches to metabolic health.